Post by Syntegon
113,567 followers
What’s fuelling growth in the liquid vial market? Two very different types of medicines. Blockbuster therapies like vaccines demand speed and high-output fill-finish lines to meet global volumes. At the same time, biopharmaceuticals and antibody-drug conjugates, often used in oncology and gene therapy, are smaller batch, highly specialized, and require flexible equipment to handle varying vial types, viscosities, and sensitivities. Add stricter regulations, including the revised EU GMP Annex 1, and the need is clear: fill-finish solutions must balance efficiency with adaptability. At Syntegon, we deliver scalable, compliant fill-finish solutions built for a changing market, ready to empower your entire lifecycle. #COCREATE #COSUCCEED #Syntegon #LifecyclePartner
Video Content